Metacrine Statistics Share Statistics Metacrine has 0
shares outstanding. The number of shares has increased by 2.97%
in one year.
Shares Outstanding n/a Shares Change (YoY) 2.97% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 31.05M Failed to Deliver (FTD) Shares 5,500 FTD / Avg. Volume 10.48%
Short Selling Information The latest short interest is 34.73K, so 0% of the outstanding
shares have been sold short.
Short Interest 34.73K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.46 and the forward
PE ratio is null.
Metacrine's PEG ratio is
0.01.
PE Ratio -0.46 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.49 P/FCF Ratio -0.6 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Metacrine.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.15,
with a Debt / Equity ratio of 0.25.
Current Ratio 10.15 Quick Ratio 9.91 Debt / Equity 0.25 Debt / EBITDA -0.23 Debt / FCF -0.3 Interest Coverage -50.81
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-6.12M Employee Count 10 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -972K Effective Tax Rate 1.56%
Stock Price Statistics The stock price has increased by -0.24% in the
last 52 weeks. The beta is -0.74, so Metacrine's
price volatility has been lower than the market average.
Beta -0.74 52-Week Price Change -0.24% 50-Day Moving Average 0.56 200-Day Moving Average 0.49 Relative Strength Index (RSI) 57.11 Average Volume (20 Days) 52,473
Income Statement
Revenue n/a Gross Profit n/a Operating Income -61.08M Net Income -61.23M EBITDA -61.08M EBIT -61.01M Earnings Per Share (EPS) -1.45
Full Income Statement Balance Sheet The company has 76.43M in cash and 14.13M in
debt, giving a net cash position of 62.3M.
Cash & Cash Equivalents 76.43M Total Debt 14.13M Net Cash 62.3M Retained Earnings -182.95M Total Assets 55.04M Working Capital 50.51M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -47.16M
and capital expenditures -8K, giving a free cash flow of -47.17M.
Operating Cash Flow -47.16M Capital Expenditures -8K Free Cash Flow -47.17M FCF Per Share -1.12
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
